J&J pauses COVID-19 vaccine trials due to unexplained illness in participant


Posted at Oct 13 2020 09:33 AM | Updated as of Oct 13 2020 09:41 AM

A laboratory researcher at the Center for Virology and Vaccine Research at Beth Israel Medical Center in New York on May 19, 2020. The center has been developing a coronavirus vaccine with Johnson & Johnson. Tony Luong, The New York Times

Johnson & Johnson said on Monday it has temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness in a study participant.

The participant's illness is being reviewed and evaluated by an independent data and safety monitoring board as well as the company's clinical and safety physicians, it said in a statement.

Stat News reported the pause earlier in the day citing a document sent to outside researchers running the 60,000-patient clinical trial, which stated that a "pausing rule" had been met, the online system used to enroll patients in the study had been closed and the data and safety monitoring board would be convened. 

(Reporting by Ayanti Bera in Bengaluru; Editing by Rashmi Aich)